Comparison of Fecal Microbiota in Children with Autism Spectrum Disorders and Neurotypical Siblings in the Simons Simplex Collection
Open accessAbstract
In order to assess potential associations between autism spectrum disorder (ASD) phenotype, functional GI disorders and fecal microbiota, we recruited simplex families, which had only a single ASD proband and neurotypical (NT) siblings, through the Simons Simplex Community at the Interactive Autism Network (SSC@IAN). Fecal samples and metadata related to functional GI disorders and diet were collected from ASD probands and NT siblings of ASD probands (age 7-14). Functional gastrointestinal disorders (FGID) were assessed using the parent-completed ROME III questionnaire for pediatric FGIDs, and problem behaviors were assessed using the Child Behavior Check List (CBCL). Targeted quantitative polymerase chain reaction (qPCR) assays were conducted on selected taxa implicated in ASD, including Sutterella spp., Bacteroidetes spp. and Prevotella spp. Illumina sequencing of the V1V2 and the V1V3 regions of the bacterial 16S rRNA genes from fecal DNA was performed to an average depth of 208,000 and 107,000 high-quality reads respectively. Twenty-five of 59 ASD children and 13 of 44 NT siblings met ROME III criteria for at least one FGID. Functional constipation was more prevalent in ASD (17 of 59) compared to NT siblings (6 of 44, P = 0.035). The mean CBCL scores in NT siblings with FGID, ASD children with FGID and ASD without FGID were comparably higher (58-62 vs. 44, P < 0.0001) when compared to NT children without FGID. There was no significant difference in macronutrient intake between ASD and NT siblings. There was no significant difference in ASD severity scores between ASD children with and without FGID. No significant difference in diversity or overall microbial composition was detected between ASD children with NT siblings. Exploratory analysis of the 16S rRNA sequencing data, however, identified several low abundance taxa binned at the genus level that were associated with ASD and/or first order ASD*FGID interactions (FDR <0.1).
AI snapshot
Written from the paper’s full text.
TL;DR
In simplex families from SSC@IAN, ASD children and their neurotypical siblings showed no significant difference in overall fecal microbial diversity or composition, but functional constipation was more common in ASD children. Exploratory 16S analyses found only low-abundance genus-level taxa associated with ASD and/or ASD*FGID interactions.
Key findings
- Among 59 ASD children and 44 NT siblings from 66 families, 25/59 ASD children (42%) and 13/44 NT siblings (30%) met ROME III criteria for at least one FGID; functional constipation was more prevalent in ASD children (17/59) than NT siblings (6/44, P = 0.035).
- Mean CBCL scores in NT siblings with FGID, ASD children with FGID, and ASD children without FGID were comparably higher than NT children without FGID (58–62 vs. 44, P < 0.0001); no significant difference in macronutrient intake was found between ASD and NT siblings, and ADOS-CSS did not differ significantly between ASD children with and without FGID.
- No significant difference in α-diversity, β-diversity, or overall microbial composition was detected between ASD children and NT siblings; targeted qPCR showed no significant differences for Sutterella, Prevotella, Bacteroidetes, C. coccoides-E. rectales, Faecalibacterium prausnitzii, or Escherichia coli.
- Exploratory 16S rRNA sequencing identified several low-abundance genus-level taxa associated with ASD and/or first-order ASD*FGID interactions at FDR < 0.1, including Cyanobacteria/Chloroplast, which was increased in the ASD-with-FGID group and appeared linked to chia seed consumption in two ASD children with functional constipation.
Methods
- Families were recruited through the Simons Simplex Community at the Interactive Autism Network (SSC@IAN); of 245 potentially eligible families with 339 children, 107 families with 145 children consented and 66 families with 103 children completed the study. Participants were ASD probands and NT siblings aged 7–14, excluding those with GI disease, serious medical problems, or antibiotics within one month of stool collection.
- Parents completed the ROME III questionnaire for pediatric FGIDs, the CBCL/6-18, and a one-week food diary; fecal samples underwent targeted qPCR for selected bacterial subgroups and Illumina sequencing of the V1V2 and V1V3 regions of bacterial 16S rRNA genes.
- Analyses included Fisher exact tests, mixed-effect models with ASD, FGID, and ASD*FGID as fixed effects and family as random effect, α-diversity indices, PERMANOVA for β-diversity, and negative binomial/zero-inflated negative binomial models for individual OTUs with Benjamini-Hochberg FDR adjustment.
Limitations
- The paper states that although this is one of the larger studies of its kind, the sample size is still modest given the number of variables included, and that additional ASD children, NT siblings (preferably family matched), and unrelated controls using the same phenotyping tools are needed to confirm the findings.
- The paper states that it may be necessary to restrict dietary intake of plant-derived supplements such as chia seeds to determine whether the Cyanobacteria/Chloroplast signal is biologically significant for ASD pathophysiology.
- Evident from the text: the study lacked unrelated NT controls, so it cannot distinguish whether NT siblings of ASD children have altered microbiomes relative to the general population; the significant microbial findings are exploratory, low-abundance, and not consistently replicated across V1V2 and V1V3 datasets.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 45 cited sources checked · 0 supported · 0 flagged
- Findingown data
No significant difference in beta-diversity was noted between ASD and NT sibling bacterial communities at the phyla, family or genus level using Bray-Curtis, Jaccard or Morisita-Horn indices.
“No significant difference (p < 0.05) was noted in β-diversity between ASD and NT sibling bacterial communities analyzed at the phyla, family or genus level and using Bray-Curtis, Jaccard or Morisita-Horn indices as dissimilarity measurements.”
Quote in the paperSubstantial claim- Rests on an assumption: The study had adequate statistical power to detect differences in the microbial outcomes measured between ASD and NT siblings.
- Findingown data
There was no significant change in the prevalence of GI symptoms in ASD children between the previous SSC registry assessment and the current study assessment approximately 2-3 years later.
“there was no significant change in the prevalence of the GI symptoms occurred over time.”
- Also stated in: § Demographics and functional GI disorders (FGID) in ASD and NT siblings · plain
“There was no significant change in the prevalence of any of the seven problematic GI symptoms in the ASD children at the two time points.”
Quote in the paperNot a substantial claim - Also stated in: § Demographics and functional GI disorders (FGID) in ASD and NT siblings · plain
- Findingown data
The mean relative abundance of the Cyanobacteria/Chloroplast genus was increased in the ASD-with FGID group compared to the other three categories (ASD without FGID, NT siblings with FGID, and NT siblings without FGID).
“The mean relative abundance of this genus was increased in the ASD-with FGID group compared to those of the other three categories (ASD without FGID, NT siblings with FGID and NT siblings without FGID, see S4 Table for mean relative abundances).”
Quote in the paperNot a substantial claim - Findingown data
No significant associations were detected between the relative abundance of the Sutterella or Prevotella genera and ASD, FGID or ASD*FGID first order interactions in either the V1V2 or V1V3 datasets.
“No significant associations were detected between the relative abundance of the Sutterella or Prevotella genera and ASD, FGID or ASD*FGID first order interactions (see Table 6) in either the V1V2 or V1V3 datasets.”
Quote in the paperNot a substantial claim - Findingown data
Inspection of the daily dietary logs of the ASD children with high counts of Chloroplast sequences revealed that these particular children were fed shakes containing chia seeds.
“Inspection of the daily dietary logs of the ASD children with high counts of Chloroplast sequences revealed that these particular children were fed shakes containing chia seeds.”
Quote in the paperSubstantial claim
- Findingown data
Exploratory analysis of the 16S rRNA sequencing data identified several low abundance taxa binned at the genus level that were associated with ASD and/or first order ASD*FGID interactions (FDR <0.1).
“Exploratory analysis of the 16S rRNA sequencing data, however, identified several low abundance taxa binned at the genus level that were associated with ASD and/or first order ASD*FGID interactions (FDR <0.1).”
Quote in the paperSubstantial claim - Findingown data
Functional constipation was more prevalent in ASD children (17 of 59) than in NT siblings (6 of 44), P = 0.035.
“Functional constipation was more prevalent in ASD (17 of 59) compared to NT siblings (6 of 44, P = 0.035).”
- Also stated in: § Demographics and functional GI disorders (FGID) in ASD and NT siblings · plain
“ASD children exhibited a higher prevalence of functional constipation in compared to NT siblings (P = 0.035) when both matched and unmatched individuals were included in the analysis.”
Quote in the paperNot a substantial claim - Also stated in: § Demographics and functional GI disorders (FGID) in ASD and NT siblings · plain
- Findingown data
Permutational Hotelling T test revealed no significant difference in the overall microbial composition when binned at the phyla level, between ASD children and NT siblings.
“Permutational Hotelling T test revealed no significant difference in the overall microbial composition when binned at the phyla level, between ASD children and NT siblings.”
Quote in the paperNot a substantial claim - Findingown data
No significant difference was observed for any of the targeted bacterial subgroups (Sutterella, Prevotella, total Bacteroidetes, C. coccoides-E. rectales, Faecalibacterium prausnitzii, Escherichia coli) in the 37 ASD/NT sibling pairs.
“No significant difference was observed for any of these bacterial subgroups in the 37 ASD/NT sibling pairs (see Methods).”
Quote in the paperSubstantial claim- Rests on an assumption: The study had adequate statistical power to detect differences in the microbial outcomes measured between ASD and NT siblings.
- Findingown data
There was no significant difference in the prevalence of specific FGIDs such as functional constipation between family-matched ASD and NT sibling pairs.
“We also detected no significant difference in the prevalence of specific FGIDs such as functional constipation in the family matched ASD/NT sibling pairs.”
Quote in the paperNot a substantial claim - Findingown data
This study did not replicate previously reported differences in the relative abundances of bacterial categories, including the Bacteroidetes phylum, the Sutterella genus, and the Prevotella genus, between ASD and unrelated control children.
“This study did not replicate previously reported differences in the relative abundances of bacterial categories, including the Bacteroidetes phylum [12–14], the Sutterella genus [7,8,10] and the Prevotella genus [11] between ASD and unrelated control children.”
Quote in the paperSubstantial claim0 of 7 sources checked- cites [12] A Tomova, 2015, Gastrointestinal microbiota in children with autism in Slovakia, Physiol Behav source
Not checked in the free run.
- cites [13] M De Angelis, 2013, Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified, PLoS One source
Not checked in the free run.
- cites [14] SM Finegold, 2010, Pyrosequencing study of fecal microbiota of autistic and control children, Anaerobe source
Not checked in the free run.
- cites [7] L Wang, 2011, Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism, Appl Environ Microbiol source
Not checked in the free run.
- cites [8] L Wang, 2013, Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder, Mol Autism source
Not checked in the free run.
- cites [10] BL Williams, 2012, Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances, MBio source
Not checked in the free run.
- cites [11] DW Kang, 2013, Reduced incidence of Prevotella and other fermenters in intestinal microbiota of autistic children, PLoS One source
Not checked in the free run.
- Findingown data
No significant differences in daily intake of macronutrients (calories, protein, fats, carbohydrates, sugars, dietary fiber) were observed between the four study groups (ASD with FGID, ASD without FGID, NT with FGID, NT without FGID).
“There was no significant difference in macronutrient intake between ASD and NT siblings.”
- Also stated in: § Comparison of CBCL and macronutrient intake · plain
“No significant differences (p < 0.05) between the four study groups with respect to daily intake of macronutrients (calories, protein, fats, carbohydrates, sugars or dietary fiber) were noted (Table 3).”
Quote in the paperNot a substantial claim- Rests on an assumption: The 7-day parent-recorded food diary accurately estimates children's daily macronutrient intake.
- Also stated in: § Comparison of CBCL and macronutrient intake · plain
- Findingown data
Twenty-five of 59 ASD children and 13 of 44 NT siblings met ROME III criteria for at least one FGID.
“Twenty-five of 59 ASD children and 13 of 44 NT siblings met ROME III criteria for at least one FGID.”
- Also stated in: § Demographics and functional GI disorders (FGID) in ASD and NT siblings · plain
“Twenty-five of 59 (42%) ASD children and 13 of 44 (30%) NT siblings were diagnosed with at least one FGID.”
Quote in the paperSubstantial claim - Also stated in: § Demographics and functional GI disorders (FGID) in ASD and NT siblings · plain
- Findingown data
Mean CBCL scores were comparably higher in NT siblings with FGID, ASD children with FGID, and ASD children without FGID (58-62) than in NT children without FGID (44), P < 0.0001.
“The mean CBCL scores in NT siblings with FGID, ASD children with FGID and ASD without FGID were comparably higher (58–62 vs. 44, P < 0.0001) when compared to NT children without FGID.”
Quote in the paperNot a substantial claim - Findingown data
There was no significant difference in mean CBCL scores between ASD children with FGID and ASD children without FGID.
“There was no significant difference in the mean CBCL scores between ASD children with FGID compared with ASD children without FGID.”
Quote in the paperNot a substantial claim - Findingown data
Exploratory analyses of individual phyla detected no significant effect (FDR <0.1) of ASD, FGID or ASD*FGID first order interactions for any of the individual phyla, including Bacteroidetes, using a negative binomial model.
“Exploratory analyses of individual phyla detected no significant effect (FDR <0.1) of ASD, FGID or ASD*FGID first order interactions for any of the individual phyla, including Bacteroidetes, using a negative binomial model.”
Quote in the paperSubstantial claim - Findingown data
With the exception of the Verrucomicrobia phylum, the relative abundances of the phyla were similar between the V1V2 and V1V3 data sets.
“With the exception of the Verrucomicrobia phylum, the relative abundances of the phyla were similar between the V1V2 and V1V3 data sets.”
Quote in the paperNot a substantial claim - Findingown data
There was no significant difference in the prevalence of at least one FGID between family-matched ASD and NT sibling pairs.
“We detected no significant difference in the prevalence of children with at least one FGID in family matched ASD/NT sibling pairs.”
Quote in the paperNot a substantial claim - Findingown data
ASD children exhibited a higher prevalence of constipation compared to NT siblings based on the SSC GI symptoms form (P = 0.05).
“Furthermore, the SSC results indicate that ASD children exhibited a higher prevalence of constipation compared to NT siblings (P = 0.05).”
Quote in the paperNot a substantial claim - Findingown data
In mixed models, no significant effect of ASD, FGID or ASD*FGID was observed for any targeted bacterial subgroup in the analysis of all 59 ASD and 44 NT siblings.
“Furthermore, in mixed models, no significant effect of ASD, FGID or ASD*FGID was observed in an analysis of all 59 ASD and 44 NT siblings.”
Quote in the paperSubstantial claim- Rests on an assumption: The study had adequate statistical power to detect differences in the microbial outcomes measured between ASD and NT siblings.
- Findingown data
Two ASD children with FGID (functional constipation), who had high relative abundances of the Cyanobacteria/Chloroplast genus and dominated the signal associated with the ASD with FGID category, were fed chia seeds added to smoothies.
“Inspection of the daily food diaries of all the subjects revealed that two ASD children with FGID (functional constipation), who had high relative abundances of this genus and consequently dominated the signal associated with ASD with FGID category, were fed chia seeds added to smoothies.”
Quote in the paperNot a substantial claim - Findingown data
There was no significant difference in ASD severity scores (ADOS-CSS) between ASD children with FGID and ASD children without FGID.
“There was no significant difference in ASD severity scores between ASD children with and without FGID.”
- Also stated in: § Comparison of CBCL and macronutrient intake · plain
“As shown in Table 3and S1 Table, the ASD severity score, ADOS-CSS, did not differ significantly between the ASD w FGID group and the ASD w/o FGID group.”
Quote in the paperNot a substantial claim - Also stated in: § Comparison of CBCL and macronutrient intake · plain
- Findingown data
CBCL scores were significantly increased in NT siblings with FGID compared to NT siblings without FGID.
“These CBCL scores were also significantly increased (p < 0.05) in NT siblings with FGID compared to NT siblings without FGID (Table 3).”
Quote in the paperNot a substantial claim - Findingown data
Both platforms detected an increased relative abundance of the low abundance Chloroplast genus in ASD compared to NT siblings.
“Both platforms detected an increased relative abundance of the low abundance Chloroplast genus in ASD compared to NT siblings.”
Quote in the paperNot a substantial claim - Findingown data
For the V1V3 dataset only, significant associations were observed for ASD and ASD*FGID first order interactions with Proteobacteria/Comamonadaceae.
“For the V1V3 dataset only, significant associations were observed for 1) ASD and ASD*FGID first order interactions with the Proteobacteria/Comamonadaceae, 2) ASD, FGID and ASD*FGID first order interactions with Fusobacteria.Fusobacteriales, 3) ASD*FGID first order interactions with Bacteroidetes/Prevotellaceae, and 4) ASD and ASD*FGID interactions with Actinobacteria/Mobiluncus.”
Quote in the paperNot a substantial claim - Findingown data
NT siblings with at least one FGID had CBCL6/18 normalized T-scores that approximated those of ASD children with or without at least one FGID.
“However, this study demonstrated that the NT siblings with at least one FGID had normalized CBCL6/18 T-scores that approximated those of ASD children with or without at least one FGID, and were also significantly higher than NT siblings without any FGIDs.”
Quote in the paperSubstantial claim - Findingown data
NT siblings with at least one FGID had significantly higher CBCL6/18 normalized T-scores than NT siblings without any FGIDs.
“However, this study demonstrated that the NT siblings with at least one FGID had normalized CBCL6/18 T-scores that approximated those of ASD children with or without at least one FGID, and were also significantly higher than NT siblings without any FGIDs.”
Quote in the paperSubstantial claim - Findingown data
In our study, the mean ADOS-CSS severity scores were not significantly different between ASD children with at least one FGID and those without any FGID.
“However, in our study, the mean ADOS-CSS severity scores, which are based on physician rather than parental evaluations, were not significantly different between the ASD children with at least one FGID and those without any FGID.”
Quote in the paperNot a substantial claim - Findingown data
For the V1V2 dataset only, significant associations were observed for ASD, FGID and ASD*FGID first order interactions with Proteobacteria/Thalassospira.
“For the V1V2 dataset only, significant associations were observed for 1) ASD and ASD*FGID first order interactions with Firmicutes/Asteroleplasma, 2) ASD, FGID and ASD*FGID first order interactions with Proteobacteria/Thalassospira, and 3) FGID and ASD*FGID first order interactions with Proteobacteria/Burkholderia (see Table 5and S4 Table).”
Quote in the paperNot a substantial claim - Findingown data
For the V1V3 dataset only, significant associations were observed for ASD*FGID first order interactions with Bacteroidetes/Prevotellaceae.
“For the V1V3 dataset only, significant associations were observed for 1) ASD and ASD*FGID first order interactions with the Proteobacteria/Comamonadaceae, 2) ASD, FGID and ASD*FGID first order interactions with Fusobacteria.Fusobacteriales, 3) ASD*FGID first order interactions with Bacteroidetes/Prevotellaceae, and 4) ASD and ASD*FGID interactions with Actinobacteria/Mobiluncus.”
Quote in the paperNot a substantial claim - Findingown data
For the V1V2 dataset only, significant associations were observed for ASD and ASD*FGID first order interactions with Firmicutes/Asteroleplasma.
“For the V1V2 dataset only, significant associations were observed for 1) ASD and ASD*FGID first order interactions with Firmicutes/Asteroleplasma, 2) ASD, FGID and ASD*FGID first order interactions with Proteobacteria/Thalassospira, and 3) FGID and ASD*FGID first order interactions with Proteobacteria/Burkholderia (see Table 5and S4 Table).”
Quote in the paperNot a substantial claim - Findingown data
The V1V3 significant associations did not reach significance in the V1V2 dataset.
“These associations, however, did not reach significance in the V1V2 dataset.”
Quote in the paperNot a substantial claim - Findingown data
ASD children with or without FGID exhibited significantly higher CBCL6/18 normalized T scores than NT siblings without FGID.
“The results of this study demonstrated that ASD children with or without FGID exhibited significantly higher scores than the NT siblings without FGID, consistent with previous studies reporting higher scores in ASD children compared to control children [34–37].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [34] CS Duarte, 2003, The CBCL and the identification of children with autism and related conditions in Brazil: pilot findings, J Autism Dev Disord source
Not checked in the free run.
- cites [35] CA Mazefsky, 2011, Child behavior checklist scores for school-aged children with autism: preliminary evidence of patterns suggesting the need for referral, J Psychopathol Behav Assess source
Not checked in the free run.
- cites [36] V Pandolfi, 2012, An initial psychometric evaluation of the CBCL 6–18 in a sample of youth with autism spectrum disorders, Res Autism Spectr Disord source
Not checked in the free run.
- cites [37] N Skokauskas, 2012, Mental health aspects of autistic spectrum disorders in children, J Intellect Disabil Res source
Not checked in the free run.
- Findingown data
For the V1V2 dataset only, significant associations were observed for FGID and ASD*FGID first order interactions with Proteobacteria/Burkholderia.
“For the V1V2 dataset only, significant associations were observed for 1) ASD and ASD*FGID first order interactions with Firmicutes/Asteroleplasma, 2) ASD, FGID and ASD*FGID first order interactions with Proteobacteria/Thalassospira, and 3) FGID and ASD*FGID first order interactions with Proteobacteria/Burkholderia (see Table 5and S4 Table).”
Quote in the paperNot a substantial claim - Findingown data
For the V1V3 dataset only, significant associations were observed for ASD and ASD*FGID interactions with Actinobacteria/Mobiluncus.
“For the V1V3 dataset only, significant associations were observed for 1) ASD and ASD*FGID first order interactions with the Proteobacteria/Comamonadaceae, 2) ASD, FGID and ASD*FGID first order interactions with Fusobacteria.Fusobacteriales, 3) ASD*FGID first order interactions with Bacteroidetes/Prevotellaceae, and 4) ASD and ASD*FGID interactions with Actinobacteria/Mobiluncus.”
Quote in the paperNot a substantial claim - Findingown data
The current study detected an increased prevalence of functional constipation FGID in ASD children compared to NT siblings that reached significance.
“The current study detected an increased prevalence of functional constipation FGID in ASD children compared to NT siblings reached significance (see Tables 1 and 2).”
Quote in the paperSubstantial claim - Findingown data
For the V1V3 dataset only, significant associations were observed for ASD, FGID and ASD*FGID first order interactions with Fusobacteria.Fusobacteriales.
“For the V1V3 dataset only, significant associations were observed for 1) ASD and ASD*FGID first order interactions with the Proteobacteria/Comamonadaceae, 2) ASD, FGID and ASD*FGID first order interactions with Fusobacteria.Fusobacteriales, 3) ASD*FGID first order interactions with Bacteroidetes/Prevotellaceae, and 4) ASD and ASD*FGID interactions with Actinobacteria/Mobiluncus.”
Quote in the paperSubstantial claim - Findingown data
A high prevalence of children diagnosed with at least one FGID was observed in both the ASD (~40%) and NT siblings (~30%) in the current study.
“A high prevalence of children diagnosed with at least one FGID was observed in both the ASD (~40%) and NT siblings (~30%) in the current study.”
Quote in the paperNot a substantial claim - Study design and conductown data
All 16S rRNA libraries had a Good's coverage score ≥ 99.9% at the rarefaction point of 15,000 sequences, indicating deep sequence coverage of the intestinal microbiome for each sample.
“All libraries had a Good’s coverage score ≥ 99.9% at the rarefaction point of 15,000 sequences, indicating deep sequence coverage of the intestinal microbiome was achieved for each sample.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The large systematic biases between MiSeq and qPCR may reflect at least in part that the depth of sequencing was not sufficient to accurately measure relatively low abundance bacterial categories.
“This may reflect at least in part that the depth of sequencing was not sufficient to accurately measure relatively low abundance bacterial categories.”
Quote in the paperNot a substantial claim - Premisecitation
Previous studies, with the exception of one study, failed to detect differences in microbial composition between ASD and NT siblings.
“Of note, previous studies [6–8,12,14], with the exception of one study [13], failed to detect differences in microbial composition between ASD and NT siblings [11].”
Quote in the paperNot a substantial claim0 of 7 sources checked- cites [6] HM Parracho, 2005, Differences between the gut microbiota of children with autistic spectrum disorders and that of healthy children, J Med Microbiol source
Not checked in the free run.
- cites [7] L Wang, 2011, Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism, Appl Environ Microbiol source
Not checked in the free run.
- cites [8] L Wang, 2013, Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder, Mol Autism source
Not checked in the free run.
- cites [12] A Tomova, 2015, Gastrointestinal microbiota in children with autism in Slovakia, Physiol Behav source
Not checked in the free run.
- cites [14] SM Finegold, 2010, Pyrosequencing study of fecal microbiota of autistic and control children, Anaerobe source
Not checked in the free run.
- cites [13] M De Angelis, 2013, Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified, PLoS One source
Not checked in the free run.
- cites [11] DW Kang, 2013, Reduced incidence of Prevotella and other fermenters in intestinal microbiota of autistic children, PLoS One source
Not checked in the free run.
- Premisecitation
The SSC represents a unique, well-described sample of able children and adolescents with relatively severe ASD, as indicated by ADI-R and ADOS Calibrated Severity Scores.
“The SSC thus represents a “unique, well-described sample of able children and adolescents with relatively severe ASD, as indicated by ADI-R and ADOS Calibrated Severity Scores (ADOS-CSS)” [32].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] GD Fischback, 2010, The Simons Simplex Collection: a resource for identification of autism genetic risk factors, Neuron source
Not checked in the free run.
- Premisecitation
A major barrier to integrating ASD studies on GI symptoms with those in the general population has been that instruments used to assess functional GI symptoms in ASD differed from the ROME III process.
“However a major barrier to integrating the ASD studies on GI symptoms with those conducted in the general population has been that the instruments used to assess functional GI symptoms in ASD differed from the ROME III process, which is the current international standard by which functional GI disorders (FGID) are diagnosed and classified [24].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] R Krajmalnik-Brown, 2015, Gut bacteria in children with autism spectrum disorders: challenges and promise of studying how a complex community influences a complex disease, Microb Ecol Health Dis
Not checked in the free run.
- Interpretationreasoning
NT siblings may have a higher prevalence of FGID than the general pediatric population.
“suggesting that NT siblings may also have a higher prevalence of FGID than the general pediatric population.”
Quote in the paperNot a substantial claim - Premisecitation
Previous studies assessing GI symptoms in ASD versus NT children suffer from methodological differences in assessing GI symptoms.
“Review of previous studies suggest that GI symptoms are more common in ASD children than in NT children, but these studies suffer from methodological differences in assessing GI symptoms [28–31].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [28] BO McElhanon, 2014, Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis, Pediatrics source
Not checked in the free run.
- cites [29] EY Hsiao, 2014, Gastrointestinal issues in autism spectrum disorder, Harv Rev Psychiatry source
Not checked in the free run.
- cites [30] GT Furuta, 2012, Management of constipation in children and adolescents with autism spectrum disorders, Pediatrics source
Not checked in the free run.
- cites [31] P Gorrindo, 2012, Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors, Autism Res source
Not checked in the free run.
- May combine two claims. 11
- Classified as probably not a substantial claim. 23
May combine two claims.
Findingown dataComparisons of the relative abundances of the Bacteroidetes phylum, and the Sutterella and Prevotella genera reveal high correlations between MiSeq V1V2 and V1V3 (ρ≈0.9) and small proportional biases.
“Comparisons of the relative abundances of the Bacteroidetes phylum, and the Sutterella and Prevotella genera reveal high correlations between MiSeq V1V2 and V1V3 (ρ≈0.9) and small proportional biases (S5 Table and S1 Fig).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNo significant effect of ASD, FGID or ASD*FGID was observed on OTU complexity or richness (Shannon diversity and Chao1) in the 16S rRNA data.
“No significant effect of ASD, FGID or ASD*FGID was observed on OTU complexity or richness, two measures of α-diversity, Shannon diversity and Chao 1 (see Table 5for mean values).”
Quote in the paperSubstantial claim- Rests on an assumption: The study had adequate statistical power to detect differences in the microbial outcomes measured between ASD and NT siblings.
May combine two claims.
Findingown dataFifteen ASD children and 13 NT siblings in 37 families met ROME III criteria for at least one FGID, with concordance for FGIDs in 6 (18%) ASD/NT sibling pairs.
“Fifteen ASD children and 13 NT siblings in 37 families met ROME III criteria for at least one FGID, with concordance for FGIDs in 6 (18%) ASD/NT sibling pairs.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenNone of the other subjects consumed chia seeds except one ASD child who ingested a serving of mixed grain bread that included chia grain.
“None of the other subjects consumed chia seeds except one ASD child who ingested a serving of mixed grain bread that included chia grain.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMean total, internalizing, externalizing and subscale CBCL scores were significantly increased in ASD children compared to NT children.
“Mean total, internalizing, externalizing and subscale CBCL scores were significantly increased (p < 0.05) in the ASD children in both the ASD/NT sibling pairs and in comparison of all the ASD with NT children (matched and unmatched).”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningWhile there were generally positively correlated measurements between the MiSeq and qPCR platforms, large systematic biases were observed particularly with the two relative low abundance genera, Sutterella and Provetella.
“While there were generally positively correlated measurements between the MiSeq and qPCR platforms, we observed large systematic biases particularly with the two relative low abundance genera, Sutterella and Provetella.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOur study detected no differences in either α or β diversity between ASD and NT siblings.
“Our study also detected no differences in either α or β diversity between ASD and NT siblings.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataPhyla of lower abundance, including RF3, Tenericutes, Cyanobacteria, Verrucomicrobia, Lentisphaerae, and Fusobacterium, were detected.
“Phyla of lower abundance, including RF3, Tenericutes, Cyanobacteria, Verrucomicrobia, Lentisphaerae, and Fusobacterium were also detected (see S3 Table).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe Silva database used in the current study binned the Melainabacteria sequences in a taxon that was distinct from the Chloroplast taxon.
“The Silva database used in the current study, however, binned the Melainabacteria sequences in a taxon that was distinct from the Chloroplast taxon.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataAt the genus level, 359 operational taxonomic units (OTU) were detected for the V1V2 dataset and 189 OTUs for the V1-V3 datasets.
“At the genus level, 359 operational taxonomic units (OTU) were detected for the V1V2 dataset and 189 OTUs for the V1-V3 datasets, respectively.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe CBCL/6-18 is a parent report form to screen for emotional, behavioral, and social problems in children ages 6-18.
“The CBCL/6-18 is a parent report form to screen for emotional, behavioral, and social problems in children ages 6–18 [33].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] TM Achenbach, 2001
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningThe failure to replicate previously reported differences may reflect the smaller number of subjects enrolled in the previous studies, possibly resulting in Type 1 errors.
“This may reflect the smaller number of subjects enrolled in the previous studies, possibly resulting in Type 1 errors.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductcitationThe p-values for each OTU were adjusted for multiple comparisons to calculate a false discovery rate using the Benjamini-Hochberg procedure.
“The p-values for each OTU were adjusted for multiple comparisons to calculate a false discovery rate (FDR) using the Benjamini-Hochberg procedure [59].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Y Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J R Statist Soc B source
Not checked in the free run.
May combine two claims.
PremisecitationStudies tracking siblings of ASD children have detected vulnerabilities in some neurocognitive domains in the absence of an ASD diagnosis, suggesting that some NT siblings may exhibit a broader subclinical ASD phenotype.
“Studies tracking siblings of ASD children have detected vulnerabilities in some neurocognitive domains in the absence of an ASD diagnosis [72] suggesting that some of the NT siblings may exhibit a broader subclinical ASD phenotype.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [72] M Wade, 2015, Using sibling designs to understand neurodevelopmental disorders: from genes and environments to prevention programming, Biomed Res Int source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationcitationAn alternative explanation for why a study comparing ASD children with NT siblings did not replicate differences reported between ASD children with unrelated controls is that NT siblings of ASD children have altered microbiomes compared to unrelated children.
“An alternative explanation for why a study comparing ASD children with NT siblings did not replicate differences reported between ASD children with unrelated controls, is that NT siblings of ASD children have altered microbiomes compared to that of unrelated children [24].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [24] R Krajmalnik-Brown, 2015, Gut bacteria in children with autism spectrum disorders: challenges and promise of studying how a complex community influences a complex disease, Microb Ecol Health Dis
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenPlasmid quantification standards were prepared from representative clones of the target organisms to ensure qPCR assays were conducted within the linear range and with similar slopes.
“Plasmid quantification standards were prepared from representative clones of the target organisms to insure that the assays were conducted within the linear range and with similar slopes.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationROME III is the current international standard by which functional GI disorders are diagnosed and classified.
“which is the current international standard by which functional GI disorders (FGID) are diagnosed and classified [24].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [24] R Krajmalnik-Brown, 2015, Gut bacteria in children with autism spectrum disorders: challenges and promise of studying how a complex community influences a complex disease, Microb Ecol Health Dis
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe qPCR assays were carried out in triplicate.
“All assays were carried out in triplicate.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationPrevious epidemiological studies using the ROME III process to survey the prevalence of a child having at least one FGID in general pediatric clinics reported a prevalence of 2% and 16%, respectively.
“Previous epidemiological studies using the ROME III process to survey the prevalence of a child having at least one FGID in general pediatric clinics reported a prevalence of 2% and 16%, respectively [73,74]”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [73] E Miele, 2004, Functional gastrointestinal disorders in children: an Italian prospective survey, Pediatrics source
Not checked in the free run.
- cites [74] GS Karabulut, 2013, The incidence of irritable bowel syndrome in children using the Rome III criteria and the effect of trimebutine treatment, J Neurogastroenterol Motil source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOne previous study used intestinal mucosal samples rather than fecal samples.
“One study used intestinal mucosal [10] rather than fecal samples.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] BL Williams, 2012, Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances, MBio source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGI symptoms are more common in ASD children than in NT children.
“Review of previous studies suggest that GI symptoms are more common in ASD children than in NT children, but these studies suffer from methodological differences in assessing GI symptoms [28–31].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [28] BO McElhanon, 2014, Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis, Pediatrics source
Not checked in the free run.
- cites [29] EY Hsiao, 2014, Gastrointestinal issues in autism spectrum disorder, Harv Rev Psychiatry source
Not checked in the free run.
- cites [30] GT Furuta, 2012, Management of constipation in children and adolescents with autism spectrum disorders, Pediatrics source
Not checked in the free run.
- cites [31] P Gorrindo, 2012, Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors, Autism Res source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenOur assessment of GI symptoms differs from previous studies in that we used the international standard for assessing FGIDs in the general pediatric population.
“Our assessment of GI symptoms differs from previous studies in that we used the international standard for assessing FGIDs in the general pediatric population.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone givenIn this study, 16S rRNA sequencing using MiSeq was carried out to a greater depth than previous studies utilizing pyrosequencing.
“In this study, 16S rRNA sequencing using MiSeq was carried out to a greater depth than previous studies utilizing pyrosequencing.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataOf the 44 NT siblings, 37 were family matched to the ASD children in the study and the remaining seven were siblings of ASD children not in the current study.
“Of the 44 NT siblings, 37 were family matched to the ASD children in the study and the remaining seven NT children were siblings of ASD children who were not in the current study, in some cases because the ASD child was older than 14 years of age.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
Study design and conductreasoningOur sample size is still modest given the number of variables included.
“Although this is one of the larger studies comparing ASD, FGID and the gut microbiota in ASD children and NT siblings, our sample size is still modest given the number of variables included.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe Actinobacteria/Mobiluncus genus has previously been associated with bacterial vaginosis.
“The Actinobacteria/Mobiluncus genus has previously been associated with bacterial vaginosis [71].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [71] RF Lamont, 2011, The vaginal microbiome: new information about genital tract flora using molecular based techniques, BJOG source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe Firmicutes/Asteroleplasma genus appears to represent a group of uncultured wall-less mycobacterium-like organisms within the class Erysipelotrichia.
“The Firmicutes/Asteroleplasma genus appears to represent a group of uncultured wall-less mycobacterium like organisms within the class Erysipelotrichia [69].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] JJ Davis, 2013, Genomes of the class Erysipelotrichia clarify the firmicute origin of the class Mollicutes, Int J Syst Evol Microbiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe Proteobacteria/Thalassospira genus appears to represent alpha-proteobacteria present in bacterioplankton and a number of uncultivated organisms.
“The Proteobacteria/Thalassospira genus appears to represent alpha-proteobacteria present in bacterioplankton and a number of uncultivated organisms [70].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [70] Q Lai, 2014, Multilocus sequence analysis for assessment of phylogenetic diversity and biogeography in Thalassospira bacteria from diverse marine environments, PLoS One source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationConstipation has been previously recognized as a significant comorbidity in ASD children.
“Constipation has been previously recognized as a significant comorbidity in ASD children [28–31].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [28] BO McElhanon, 2014, Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis, Pediatrics source
Not checked in the free run.
- cites [29] EY Hsiao, 2014, Gastrointestinal issues in autism spectrum disorder, Harv Rev Psychiatry source
Not checked in the free run.
- cites [30] GT Furuta, 2012, Management of constipation in children and adolescents with autism spectrum disorders, Pediatrics source
Not checked in the free run.
- cites [31] P Gorrindo, 2012, Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors, Autism Res source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMetagenomic studies have detected a novel nonphotosynthetic taxon termed "Melainabacteria" present in human gut flora that represents either a sibling phylum or a class within the Cyanobacteria phylum.
“Metagenomic studies have detected a novel nonphotosynthetic taxa termed “Melainabacteria” present in human gut flora that represents either a sibling phylum or a class within the Cyanobacteria phylum [65,66].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [65] SC Di Rienzi, 2013, The human gut and groundwater harbor non-photosynthetic bacteria belonging to a new candidate phylum sibling to Cyanobacteria, Elife source
Not checked in the free run.
- cites [66] RM Soo, 2014, An expanded genomic representation of the phylum cyanobacteria, Genome Biol Evol source
Not checked in the free run.
The paper relies on this without support.
The 7-day parent-recorded food diary accurately estimates children's daily macronutrient intake.
“The parents were asked to record the daily dietary intake of ASD and NT siblings on the Stony Brook University Medical Center Department of Pediatrics Food Diary/Calorie Count sheet for 7 days prior to the collection of the stool sample.”
The paper relies on this without support.
The study had adequate statistical power to detect differences in the microbial outcomes measured between ASD and NT siblings.
“No significant difference in diversity or overall microbial composition was detected between ASD children with NT siblings.”
“No significant difference was observed for any of these bacterial subgroups in the 37 ASD/NT sibling pairs (see Methods).”
The paper relies on this without support.
The study had adequate statistical power to detect differences in macronutrient intake between ASD and NT siblings.
“There was no significant difference in macronutrient intake between ASD and NT siblings.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Two studies showed increases in alpha diversity and six studies showed no significant changes in alpha diversity.
“Two studies showed increases [31, 33] and six studies showed no significant changes in alpha diversity [36, 42, 43, 48, 50, 54].”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
The rest of the studies observed either a decrease in Bacteroidetes percentage or no significant differences between cases and controls.
“The rest of the studies observed either a decrease in Bacteroidetes percentage [50, 54] or no significant differences between cases and controls [31, 36, 48].”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
Among seven papers reporting beta diversity, four showed significant differences in beta diversity between ASD and SIB/HC while the rest did not.
“Among the seven [31, 36, 40–42, 48, 50] papers that reported on beta diversity, four [31, 40, 41, 50] papers showed significant differences in beta diversity between ASD and SIB/HC while the rest did not (Additional file 1: Table S2).”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
At the Firmicutes phylum level, none of the six studies showed an increase in absolute or relative abundance.
“At the phylum level, none of the six studies showed an increase in absolute or relative abundance [31, 33, 36, 48, 51, 54].”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
The two studies on absolute abundance of Firmicutes did not reveal any differences between ASD, SIB, and HC.
“The two studies on absolute abundance did not reveal any differences between ASD, SIB, and HC [48, 51].”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
These seven Prevotella studies showed either a non-significant result in relative abundance or a lower relative abundance in children classified as ASD versus SIB or HC.
“Instead, these seven studies showed either a non-significant result in relative abundance [41, 48, 50, 52] or a lower relative abundance in children classified as ASD versus SIB or HC [31, 39, 42].”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
Cluster XIVa and XIVb were quantitatively similar in percentage and counts in the available four studies.
“Cluster XIVa and XIVb, however, were quantitatively similar in percentage [52] and counts [45, 48, 49] in the available four studies.”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
For relative abundance in total and metabolically active Firmicutes, studies demonstrated either a decrease or no significant differences between children with ASD, SIB, and HC.
“For relative abundance in both total and metabolically active Firmicutes, the studies demonstrated either a decrease [31, 33, 36] or no significant differences between children with ASD, SIB, and HC [48, 51, 54].”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
Actinobacteria as a phylum did not reveal any compelling results.
“Actinobacteria as a phylum did not reveal any compelling results [33, 36, 48];”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
Despite speculation that Sutterella was increased in children with ASD, this was not true in every study; three studies suggested no significant differences and one suggested a decrease.
“Despite speculation that Sutterella was increased in children with ASD [53, 55], this was not true in every study. There were three studies suggesting no significant differences [38, 41, 48] and one suggesting a decrease [44], but this particular study included adolescents in their cohort.”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
The general trend supports no alterations in E. coli for children with ASD in five studies versus one study documenting a decrease in E. coli percentage.
“The general trend, however, supports no alterations in E. coli for children in ASD in five studies [30, 35, 42, 48, 52] vs one study [31] documenting a decrease in E. coli percentage among other microbiota.”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
Fusobacteria phylum suggested a lower relative abundance in children with ASD versus unaffected siblings, although one study demonstrated the opposite in terms of Fusobacterium absolute numbers.
“Fusobacteria phylum suggested a lower relative abundance in children with ASD vs unaffected siblings, although one study [48] demonstrated the opposite in terms of Fusobacterium absolute numbers.”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
No specific findings were identified in the Verrucomicrobia phylum and in the Verrucomicrobiaceae family.
“No specific findings were identified in the Verrucomicrobia phylum [31, 33, 36, 39, 48] and in the Verrucomicrobiaceae family [31, 37, 39, 41, 52].”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
In this review, only a few studies have involved developmental specialists and psychologists apt in monitoring changes in ASD symptoms.
“In this review, only a few studies have involved developmental specialists and psychologists who are apt in monitoring changes in ASD symptoms [32, 48].”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
One study suggests children with ASD may have increased intake of chia seeds in smoothies, associated with specific microbiome findings.
“One study suggests that children with ASD may have an increased intake of chia seeds in smoothies, which is associated with specific microbiome findings [48].”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [48]
More recent studies failed to reach a consensus as to whether an ASD-specific microbial signature exists.
“but more recent studies failed to reach a consensus as to whether an ASD-specific microbial signature exists.24, 51”
From Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder (2017) · cites this paper as [51]
Son et al. conducted further nutritional analysis of one-week food diary and found no significant difference between the two groups with respect to daily intake of macronutrients (calories, protein, fats, carbohydrates, sugars or dietary fiber).
“In addition, Son et al.21 conducted further nutritional analysis of one-week food diary, no significant difference between two group with respect to daily intake of macronutrients (calories, protein, fats, carbohydrates, sugars or dietary fiber) were noted.”
From Altered composition and function of intestinal microbiota in autism spectrum disorders: A systematic review (2019) · cites this paper as [21]
Son et al., De Angelis et al. and Gondalia et al. recruited healthy siblings as control, whereas other studies recruited normal control from the whole population.
“Besides, Son et al.21, De Angelis et al.23 and Gondalia et al.26 recruited healthy siblings as control, whereas other studies recruited normal control from the whole population.”
From Altered composition and function of intestinal microbiota in autism spectrum disorders: A systematic review (2019) · cites this paper as [21]
In Son et al., there was no difference of functional modules between ASD patients and healthy controls.
“Whereas, in the study of Son et al.21, there was no difference of functional modules between ASD patients and HCs, which was accordance with the result of gut microbiota composition.”
From Altered composition and function of intestinal microbiota in autism spectrum disorders: A systematic review (2019) · cites this paper as [21]
It can be an alternative explanation that studies using NT sibling controls did not find any significant difference, while other studies using non-sibling controls did.
“It can be an alternative explanation that why studies21,26 using NT sibling controls did not find any significant difference, while other studies using non-sibling controls did.”
From Altered composition and function of intestinal microbiota in autism spectrum disorders: A systematic review (2019) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Completed-study group counts conflict
MajorThe methods say 66 ASD children and 37 NT siblings completed the study, while the results say 59 ASD children and 44 NT siblings completed it. Both descriptions total 103 children but assign seven children to different groups.
“66 families with 103 children (66 ASD probands and 37 NT siblings) completed the study.”
“A total of 59 ASD children and 44 NT siblings from 66 families completed the study (Table 1).”
Diet-restriction total disagrees with Table 3
MinorThe four groups in Table 3 list 1, 3, 0, and 1 children on a gluten- or casein-free diet, totaling five rather than four.
Reported 4 · recomputed 5
“Only 4 children were reported to adhere to a gluten and/or casein free diet.”
FGID concordance percentage uses the wrong denominator
MinorSix of the 37 matched sibling pairs is 16.2%, not the reported 18%.
Reported 18 · recomputed 16.216216
“with concordance for FGIDs in 6 (18%) ASD/NT sibling pairs.”
Matched NT sibling FGID count differs from Table 1
MinorThe results text says 13 matched NT siblings had an FGID, but Table 1 reports 12.
“Fifteen ASD children and 13 NT siblings in 37 families met ROME III criteria for at least one FGID”
“| FGID present (family matched) | 15 (41%) | 12 (32%) | 0.31 |”
H1b and H1c diagnoses are reversed in Table 1
MinorThe results text identifies H1b as cyclic vomiting syndrome and H1c as aerophagia, while Table 1 assigns those labels the other way around.
“H1b) Cyclic vomiting syndrome; H1c) Aerophagia.”
“| H1b. Aerophagia | 2 | 2 | 0.44 | | H1c. Cyclic Vomiting Syndrome | 0 | 1 | 0.33 |”
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., & Glöckner, F. O. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1219 · Cited by 33,055 · see citing works
<b>lavaan</b> : An <i>R</i> Package for Structural Equation Modeling
Rosseel, Y. (2012) · Journal of Statistical Software · doi:10.18637/jss.v048.i02 · Cited by 27,955 · see citing works
vegan: Community Ecology Package
Oksanen, J., Simpson, G. L., Blanchet, F. G., Kindt, R., Legendre, P., Minchin, P. R., O’Hara, R. B., Sólymos, P., Stevens, M. H. H., Szöcs, E., et al. (2001) · doi:10.32614/cran.package.vegan · Cited by 27,099 · see citing works
Biometry: The Principles and Practice of Statistics in Biological Research
Sokal, R. R., & Rohlf, F. J. (1969) · Cited by 20,963 · see citing works
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114 · see citing works
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828 · see citing works
Base-Calling of Automated Sequencer Traces Using Phred. I. Accuracy AssessmentPreprint
Ewing, B., Hillier, L., Wendl, M. C., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.175 · Cited by 6,993 · see citing works
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., Kurzius-Spencer, M., Zahorodny, W., Robinson, C., Rosenberg, et al. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6706a1 · Cited by 6,078 · see citing works
Linear Mixed-Effects Models using 'Eigen' and S4
Bates, D. M., Maechler, M., Bolker, B. M., & Walker, S. C. (2015) · Cited by 5,924 · see citing works
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · see citing works
Self-citationMaenner, M. J., Shaw, K. A., Baio, J., EdS1, Washington, A., Patrick, M., DiRienzo, M., Christensen, D. L., Wiggins, L. D., Pettygrove, S., et al. (2020) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6904a1 · Cited by 3,780 · see citing works
SINA: Accurate high-throughput multiple sequence alignment of ribosomal RNA genes
Pruesse, E., Peplies, J., & Glöckner, F. (2012) · Bioinform. · doi:10.1093/bioinformatics/bts252 · Cited by 2,989 · see citing works
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952 · see citing works
Waste Not, Want Not: Why Rarefying Microbiome Data Is Inadmissible
McMurdie, P. J., & Holmes, S. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003531 · Cited by 2,894 · see citing works
Navigating the multiple meanings of β diversity: a roadmap for the practicing ecologist
Anderson, M. J., Crist, T. O., Chase, J. M., Vellend, M., Inouye, B. D., Freestone, A. L., Sanders, N. J., Cornell, H. V., Comita, L. S., Davies, K. F., et al. (2010) · Ecology Letters · doi:10.1111/j.1461-0248.2010.01552.x · Cited by 2,503 · see citing works
Manual for the ASEBA preschool forms and profiles
Achenbach, T. M., & Rescorla, L. (2000) · Cited by 2,502 · see citing works
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity
Markle, J. G. M., Frank, D. N., Mortin-Toth, S., Robertson, C. E., Feazel, L. M., Rolle-Kampczyk, U., von Bergen, M., McCoy, K. D., Macpherson, A. J., & Danska, J. S. (2013) · Science · doi:10.1126/science.1233521 · Cited by 2,025 · see citing works
Self-citationChildhood Functional Gastrointestinal Disorders: Child/Adolescent
Rasquin, A., Lorenzo, C. D., Forbes, D., Guiraldes, E., Hyams, J. S., Staiano, A., & Walker, L. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.08.063 · Cited by 1,785 · see citing works
Naarden Braun, K. V., Lopez, M., White, T., et al. (2023) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/y3kk-5x30 · Cited by 1,381 · see citing works
Adams, J. B., Johansen, L. J., Powell, L. D., Quig, D., & Rubin, R. A. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-22 · Cited by 1,076 · see citing works
Rajilić–Stojanović, M., Biagi, E., Heilig, H. G. H. J., Kajander, K., Kekkonen, R. A., Tims, S., & de Vos, W. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.043 · Cited by 1,041 · see citing works
Rinttilä, T., Kassinen, A., Malinen, E., Krogius-Kurikka, L., & Palva, A. (2004) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2004.02409.x · Cited by 1,018 · see citing works
Pyrosequencing study of fecal microflora of autistic and control children
Finegold, S. M., Dowd, S. E., Gontcharova, V., Liu, C., Henley, K. E., Wolcott, R. D., Youn, E., Summanen, P. H., Granpeesheh, D., Dixon, D., et al. (2010) · Anaerobe · doi:10.1016/j.anaerobe.2010.06.008 · Cited by 977 · see citing works
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children
Kang, D.-W., Park, J. G., Ilhan, Z. E., Wallstrom, G., LaBaer, J., Adams, J. B., & Krajmalnik-Brown, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068322 · Cited by 976 · see citing works
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939 · see citing works
De Angelis, M., Piccolo, M., Vannini, L., Siragusa, S., De Giacomo, A., Serrazzanetti, D. I., Cristofori, F., Guerzoni, M. E., Gobbetti, M., & Francavilla, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076993 · Cited by 887 · see citing works
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota
Jeffery, I. B., O'Toole, P. W., Öhman, L., Claesson, M. J., Deane, J., Quigley, E. M. M., & Simrén, M. (2012) · Gut · doi:10.1136/gutjnl-2011-301501 · Cited by 835 · see citing works
Gastrointestinal Symptoms in Autism Spectrum Disorder: A Meta-analysis
McElhanon, B. O., McCracken, C., Karpen, S., & Sharp, W. G. (2014) · Pediatrics · doi:10.1542/peds.2013-3995 · Cited by 831 · see citing works
Parracho, H. M., Bingham, M. O., Gibson, G. R., & McCartney, A. L. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46101-0 · Cited by 784 · see citing works
Schloss, P. D., & Westcott, S. L. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.02810-10 · Cited by 726 · see citing works
The Simons Simplex Collection: a resource for identification of autism genetic risk factors
Fischbach, G. D., & Lord, C. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.006 · Cited by 725 · see citing works
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome
Saulnier, D. M., Riehle, K., Mistretta, T., Diaz, M., Mandal, D., Raza, S., Weidler, E. M., Qin, X., Coarfa, C., Milosavljevic, A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.072 · Cited by 672 · see citing works
Gastrointestinal microbiota in children with autism in Slovakia
Tomova, A., Husarova, V., Lakatosova, S., Bakos, J., Vlkova, B., Babinska, K., & Ostatnikova, D. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.10.033 · Cited by 632 · see citing works
Heritability of Autism Spectrum Disorder in a UK Population-Based Twin Sample
Colvert, E., Tick, B., McEwen, F., Stewart, C., Curran, S. R., Woodhouse, E., Gillan, N., Hallett, V., Lietz, S., Garnett, T., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.3028 · Cited by 560 · see citing works
Maeda, H. A., Fujimoto, C., Haruki, Y., Maeda, T., Kokeguchi, S., Petelin, M., Arai, H., Tanimoto, I., Nishimura, F., & Takashiba, S. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00224-4 · Cited by 502 · see citing works
The vaginal microbiome: new information about genital tract flora using molecular based techniques
Lamont, R., Sobel, J. D., Akins, R. A., Hassan, S., Chaiworapongsa, T., Kusanovic, J. P., & Romero, R. J. (2011) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02840.x · Cited by 481 · see citing works
Wang, L., Christophersen, C. T., Sorich, M. J., Gerber, J. P., Angley, M. T., & Conlon, M. A. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05212-11 · Cited by 432 · see citing works
Wang, L., Christophersen, C. T., Sorich, M. J., Gerber, J. P., Angley, M. T., & Conlon, M. A. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-42 · Cited by 418 · see citing works
Rienzi, S. C. D., Sharon, I., Wrighton, K. C., Koren, O., Hug, L. A., Thomas, B. C., Goodrich, J. K., Bell, J. T., Spector, T. D., Banfield, J. F., et al. (2013) · eLife · doi:10.7554/elife.01102 · Cited by 404 · see citing works
Williams, B. L., Hornig, M., Parekh, T., & Lipkin, W. I. (2012) · mBio · doi:10.1128/mbio.00261-11 · Cited by 378 · see citing works
Brain–gut connections in functional GI disorders: Anatomic and physiologic relationships
Jones, M. P., Dilley, J. B., Drossman, D., & Crowell, M. D. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00730.x · Cited by 358 · see citing works
Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors
Gorrindo, P., Williams, K. C., Lee, E. B., Walker, L. S., McGrew, S. G., & Levitt, P. (2012) · Autism Research · doi:10.1002/aur.237 · Cited by 325 · see citing works
HANDBOOK OF BIOLOGICAL STATISTICS
Mcdonald, J. H. (2024) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.13512186 · Cited by 307 · see citing works
An Expanded Genomic Representation of the Phylum Cyanobacteria
Soo, R. M., Skennerton, C. T., Sekiguchi, Y., Imelfort, M., Paech, S. J., Dennis, P. G., Steen, J. A., Parks, D. H., Tyson, G. W., & Hugenholtz, P. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evu073 · Cited by 290 · see citing works
Robertson, C. E., Harris, J. K., Wagner, B. D., Granger, D., Browne, K., Tatem, B., Feazel, L. M., Park, K., Pace, N. R., & Frank, D. N. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt526 · Cited by 286 · see citing works
Self-citationLi, E., Hamm, C. M., Gulati, A., Sartor, R. B., Chen, H., Wu, X., Zhang, T., Rohlf, F. J., Zhu, W., Gu, C. C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0026284 · Cited by 236 · see citing works
Self-citationKim, Y. S., & LEVENTHAL, B. L. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.001 · Cited by 229 · see citing works
Gastrointestinal issues in autism spectrum disorder
Hsiao, E. Y. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000029 · Cited by 209 · see citing works
Gondalia, S. V., Palombo, E. A., Knowles, S. R., Cox, S. B., Meyer, D., & Austin, D. W. (2012) · Autism Research · doi:10.1002/aur.1253 · Cited by 208 · see citing works
Kim, S.-E., Choi, S. C., Park, K. S., Park, M. I., Shin, J. E., Lee, T. H., Jung, K. W., Koo, H. S., & Myung, S.-J. (2015) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm14048 · Cited by 180 · see citing works
Functional Gastrointestinal Disorders in Children: An Italian Prospective Survey
Miele, E., Simeone, D., Marino, A., Greco, L., Auricchio, R., Novek, S. J., & Staiano, A. (2004) · PEDIATRICS · doi:10.1542/peds.114.1.73 · Cited by 177 · see citing works
Pandolfi, V., Magyar, C. I., & Dill, C. A. (2012) · Research in Autism Spectrum Disorders · doi:10.1016/j.rasd.2011.03.009 · Cited by 175 · see citing works
Investigating the biological and clinical significance of human dysbioses
Frank, D. N., Zhu, W., Sartor, R. B., & Li, E. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.06.005 · Cited by 174 · see citing works
Self-citationKrajmalnik‐Brown, R., Lozupone, C., Kang, D., & Adams, J. B. (2015) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v26.26914 · Cited by 167 · see citing works
Mazefsky, C. A., Anderson, R., Conner, C. M., & Minshew, N. (2011) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-010-9198-1 · Cited by 127 · see citing works
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome
Ringel, Y., & Maharshak, N. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00207.2012 · Cited by 115 · see citing works
Duarte, C. S., Bordin, I. A. S., Oliveira, A. D., & Bird, H. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/b:jadd.0000006005.31818.1c · Cited by 113 · see citing works
Prevention of Virus-Induced Type 1 Diabetes with Antibiotic Therapy
Hara, N., Alkanani, A. K., Ir, D., Robertson, C. E., Wagner, B. D., Frank, D. N., & Zipris, D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201257 · Cited by 106 · see citing works
Self-citationSchneider, C. K., Melmed, R. D., Barstow, L. E., Enriquez, F. J., Ranger‐Moore, J., & Ostrem, J. A. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0141-y · Cited by 96 · see citing works
Management of constipation in children and adolescents with autism spectrum disorders
Furuta, G. T., Williams, K., Kooros, K., Kaul, A., Panzer, R., Coury, D. L., & Fuchs, G. (2012) · PEDIATRICS · doi:10.1542/peds.2012-0900h · Cited by 88 · see citing works
Gulati, A., Shanahan, M. T., Arthur, J. C., Grossniklaus, E. J., von Furstenberg, R. J., Kreuk, L. S. M., Henning, S., Jobin, C., & Sartor, R. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032403 · Cited by 78 · see citing works
Karabulut, G. S., Beşer, Ö. F., Erginöz, E., Kutlu, T., Cokugras, F. C., & Erkan, T. (2013) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2013.19.1.90 · Cited by 76 · see citing works
Mental health aspects of autistic spectrum disorders in children
Skokauskas, N., & Gallagher, L. (2012) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2011.01423.x · Cited by 75 · see citing works
Genomes of the class Erysipelotrichia clarify the firmicute origin of the class Mollicutes
Davis, J. J., Xia, F., Overbeek, R., & Olsen, G. J. (2013) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijs.0.048983-0 · Cited by 47 · see citing works
Perilipin-2 Modulates Lipid Absorption and Microbiome Responses in the Mouse Intestine
Frank, D. N., Bales, E. S., Monks, J., Jackman, M. J., MacLean, P. S., Ir, D., Robertson, C. E., Orlicky, D. J., & McManaman, J. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131944 · Cited by 46 · see citing works
Self-citationWade, M., Prime, H., & Madigan, S. (2015) · BioMed Research International · doi:10.1155/2015/672784 · Cited by 41 · see citing works
Kim, R. J. T., Biswas, K., Hoggard, M., Taylor, M. W., & Douglas, R. G. (2015) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21600 · Cited by 37 · see citing works
Lai, Q., Liu, Y., Yuan, J., Du, J., Wang, L., Sun, F., & Shao, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106353 · Cited by 37 · see citing works
Do gut microbial communities differ in pediatric IBS and health?
Shankar, V., Agans, R., Holmes, B., Raymer, M. G., & Paliy, O. (2013) · Gut Microbes · doi:10.4161/gmic.24827 · Cited by 36 · see citing works
Wu, X., Berkow, K. S., Frank, D. N., Li, E., Gulati, A., & Zhu, W. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-79 · Cited by 9 · see citing works
Self-citation(1999) · Journal of Systems and Software · doi:10.1016/s0164-1212(99)00040-0 · Cited by 4 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- R Krajmalnik-Brown, 2015, Gut bacteria in children with autism spectrum disorders: challenges and promise of studying how a complex community influences a complex disease, Microb Ecol Health Dis, 26, 26914
- Y Rosseel, 2012, lavaanAn R package for structural equation modeling, JSS, 48, 1
Cited by
Sorted by citations
The gut microbiota–brain axis in behaviour and brain disorders
Morais, L. H., Schreiber, H. L., & Mazmanian, S. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00460-0 · Cited by 2,149 · see citing works
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,548 · see citing works
The central nervous system and the gut microbiome
Sharon, G., Sampson, T. R., Geschwind, D. H., & Mazmanian, S. K. (2016) · Cell · doi:10.1016/j.cell.2016.10.027 · Cited by 1,513 · see citing works
Kang, D.-W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0225-7 · Cited by 1,391 · see citing works
Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice
Sharon, G., Cruz, N. J., Kang, D.-W., Gandal, M. J., Wang, B., Kim, Y.-M., Zink, E. M., Casey, C. P., Taylor, B. C., Lane, C. J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.004 · Cited by 1,182 · see citing works
New evidences on the altered gut microbiota in autism spectrum disorders
Strati, F., Cavalieri, D., Albanese, D., De Felice, C., Donati, C., Hayek, J., Jousson, O., Leoncini, S., Renzi, D., Calabrò, A., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0242-1 · Cited by 1,040 · see citing works
Microbiome differential abundance methods produce different results across 38 datasets
Nearing, J. T., Douglas, G. M., Hayes, M. G., MacDonald, J., Desai, D., McCormick, N. E., Jones, C. M. A., Wright, R., Dhanani, A. S., Comeau, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28034-z · Cited by 989 · see citing works
Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration
Dinan, T. G., & Cryan, J. F. (2017) · The Journal of Physiology · doi:10.1113/jp273106 · Cited by 813 · see citing works
Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota
Kang, D.-W., Adams, J. B., Coleman, D. M., Pollard, E. L., Maldonado, J., McDonough-Means, S., Caporaso, J. G., & Krajmalnik-Brown, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-42183-0 · Cited by 749 · see citing works
Feeding the microbiota–gut–brain axis: Diet, microbiome, and neuropsychiatry
Sandhu, K. V., Sherwin, E., Schellekens, H., Stanton, C., Dinan, T. G., & Cryan, J. F. (2017) · Translational Research · doi:10.1016/j.trsl.2016.10.002 · Cited by 491 · see citing works
The Gut Microbiota and Autism Spectrum Disorders
Li, Q., Han, Y., Dy, A. B. C., & Hagerman, R. J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00120 · Cited by 462 · see citing works
Microbiota and the social brain
Sherwin, E., Bordenstein, S. R., Quinn, J. L., Dinan, T. G., & Cryan, J. F. (2019) · Science · doi:10.1126/science.aar2016 · Cited by 462 · see citing works
Fecal Microbiota Transplantation in Neurological Disorders
Vendrik, K. E. W., Ooijevaar, R. E., de Jong, P. R. C., Laman, J. D., van Oosten, B. W., van Hilten, J. J., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., & Contarino, M. F. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00098 · Cited by 413 · see citing works
The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder
Srikantha, P., & Mohajeri, M. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092115 · Cited by 400 · see citing works
Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders
Kang, D.-W., Ilhan, Z. E., Isern, N. G., Hoyt, D. W., Howsmon, D. P., Shaffer, M., Lozupone, C. A., Hahn, J., Adams, J. B., & Krajmalnik-Brown, R. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2017.12.007 · Cited by 381 · see citing works
Iglesias-Vázquez, L., Van Ginkel Riba, G., Arija, V., & Canals, J. (2020) · Nutrients · doi:10.3390/nu12030792 · Cited by 352 · see citing works
Autism-related dietary preferences mediate autism-gut microbiome associations
Yap, C. X., Henders, A. K., Alvares, G. A., Wood, D., Krause, L., Tyson, G. W., Restuadi, R., Wallace, L. M., McLaren, T., Hansell, N. K., et al. (2021) · Cell · doi:10.1016/j.cell.2021.10.015 · Cited by 359 · see citing works
Mucosal Prevalence and Interactions with the Epithelium Indicate Commensalism of Sutterella spp.
Hiippala, K., Kainulainen, V., Kalliomäki, M., Arkkila, P., & Satokari, R. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01706 · Cited by 351 · see citing works
“Sutterella parvirubra adhered better than the two other Sutterella spp. to differentiated Caco-2 cells and was capable of decreasing the adherence of S. wadsworthensis, which preferably bound to mucus and human extracellular matrix proteins.”
BackgroundLiu, F., Li, J., Wu, F., Zheng, H., Peng, Q., & Zhou, H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0389-6 · Cited by 336 · see citing works
Brain-Gut-Microbiota Axis and Mental Health
Dinan, T. G., & Cryan, J. F. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000519 · Cited by 325 · see citing works
Heiss, C. N., & Olofsson, L. E. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12684 · Cited by 304 · see citing works
Sherwin, E., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2016) · CNS Drugs · doi:10.1007/s40263-016-0370-3 · Cited by 297 · see citing works
Luna, R. A., Oezguen, N., Balderas, M., Venkatachalam, A., Runge, J. K., Versalovic, J., Veenstra-VanderWeele, J., Anderson, G. M., Savidge, T., & Williams, K. C. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.11.008 · Cited by 295 · see citing works
Cross talk: the microbiota and neurodevelopmental disorders
Kelly, J. R., Minuto, C., Cryan, J. F., Clarke, G., & Dinan, T. G. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00490 · Cited by 271 · see citing works
Liu, Y.-W., Liong, M., Chung, Y.-C. E., Huang, H.-Y., Peng, W.-S., Cheng, Y.-F., Lin, Y.-S., Wu, Y., & Tsai, Y.-C. (2019) · Nutrients · doi:10.3390/nu11040820 · Cited by 268 · see citing works
Wirbel, J., Zych, K., Essex, M., Karcher, N., Kartal, E., Salazar, G., Bork, P., Sunagawa, S., & Zeller, G. (2021) · Genome Biology · doi:10.1186/s13059-021-02306-1 · Cited by 269 · see citing works
Gut microbiome composition and diversity are related to human personality traits
Johnson, K. V. ‐. (2019) · Human Microbiome Journal · doi:10.1016/j.humic.2019.100069 · Cited by 241 · see citing works
The Microbiome in Psychology and Cognitive Neuroscience
Sarkar, A., Harty, S., Lehto, S. M., Moeller, A. H., Dinan, T. G., Dunbar, R., Cryan, J. F., & Burnet, P. W. J. (2018) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2018.04.006 · Cited by 231 · see citing works
Rose, D. R., Yang, H., Serena, G., Sturgeon, C., Ma, B., Careaga, M., Hughes, H. K., Angkustsiri, K., Rose, M., Hertz-Picciotto, I., et al. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.03.025 · Cited by 227 · see citing works
The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders
Hughes, H. K., Rose, D., & Ashwood, P. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0887-6 · Cited by 225 · see citing works
Epigenetic Matters: The Link between Early Nutrition, Microbiome, and Long-term Health Development
Indrio, F., Martini, S., Francavilla, R., Corvaglia, L., Cristofori, F., Mastrolia, S. A., Neu, J., Rautava, S., Spena, G. R., Raimondi, F., et al. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00178 · Cited by 232 · see citing works
Morton, J. T., Jin, D.-M., Mills, R. H., Shao, Y., Rahman, G., McDonald, D. T., Zhu, Q., Balaban, M., Jiang, Y., Cantrell, K., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01361-0 · Cited by 229 · see citing works
Self-citationAltered Gut Microbiota in Chinese Children With Autism Spectrum Disorders
Ma, B., Liang, J., Dai, M., Wang, J., Luo, J., Zhang, Z., & Jing, J. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00040 · Cited by 197 · see citing works
Qiao, Y., Wu, M., Feng, Y., Zhou, Z., Chen, L., & Chen, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-19982-y · Cited by 170 · see citing works
Moreno-Pérez, D., Bressa, C., Bailén, M., Hamed-Bousdar, S., Naclerio, F., Carmona, M., Pérez, M., González-Soltero, R., Montalvo-Lominchar, M., Carabaña, C., et al. (2018) · Nutrients · doi:10.3390/nu10030337 · Cited by 158 · see citing works
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Forsythe, P., Kunze, W., & Bienenstock, J. (2016) · BMC Medicine · doi:10.1186/s12916-016-0604-8 · Cited by 155 · see citing works
Gut microbiota changes in children with autism spectrum disorder: a systematic review
Ho, L. K. H., Tong, V. J. W., Syn, N., Nagarajan, N., Tham, E. H., Tay, S. K., Shorey, S., Tambyah, P. A., & Law, E. C. N. (2020) · Gut Pathogens · doi:10.1186/s13099-020-0346-1 · Cited by 149 · see citing works
Microbiome and nutrition in autism spectrum disorder: Current knowledge and research needs
Berding, K., & Donovan, S. M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw048 · Cited by 146 · see citing works
Kong, X., Liu, J., Çetinbaş, M., Sadreyev, R. I., Koh, M., Huang, H. Y., Adeseye, A., He, P., Zhu, J., Russell, H., et al. (2019) · Nutrients · doi:10.3390/nu11092128 · Cited by 145 · see citing works
Diet can impact microbiota composition in children with autism spectrum disorder
Berding, K., & Donovan, S. M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00515 · Cited by 144 · see citing works
Autism Spectrum Disorder as a Brain-Gut-Microbiome Axis Disorder
Saurman, V. E., Margolis, K. G., & Luna, R. A. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06133-5 · Cited by 140 · see citing works
The role of the microbiome in the neurobiology of social behaviour
Sarkar, A., Harty, S., Johnson, K. V. ‐., Moeller, A. H., Carmody, R. N., Lehto, S. M., Erdman, S. E., Dunbar, R. I. M., & Burnet, P. W. J. (2020) · Biological Reviews · doi:10.1111/brv.12603 · Cited by 135 · see citing works
Spichak, S., Bastiaanssen, T. F. S., Berding, K., Vlckova, K., Clarke, G., Dinan, T. G., & Cryan, J. F. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.044 · Cited by 127 · see citing works
The Gut-Microglia Connection: Implications for Central Nervous System Diseases
Wang, Y., Wang, Z., Wang, Y., Li, F., Jia, J., Song, X., Qin, S., Wang, R., Jin, F., Kitazato, K., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02325 · Cited by 128 · see citing works
Bundgaard‐Nielsen, C., Knudsen, J. K., Leutscher, P. D. C., Lauritsen, M. B., Nyegaard, M., Hagstrøm, S., & Sørensen, S. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1748258 · Cited by 118 · see citing works
Cattane, N., Richetto, J., & Cattaneo, A. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.001 · Cited by 118 · see citing works
Liu, J., Liu, X., Xiong, X.-Q., Yang, T., Cui, T., Hou, N.-L., Lai, X., Liu, S., Guo, M., Liang, X.-H., et al. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1096-1 · Cited by 115 · see citing works
García-Gutiérrez, E., Narbad, A., & Rodríguez, J. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.578666 · Cited by 115 · see citing works
Diet: the keystone of autism spectrum disorder?
Peretti, S., Mariano, M. R. G., Mazzocchetti, C., Mazza, M., Pino, M. C., di Pianella, A. V., & Valenti, M. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1464819 · Cited by 106 · see citing works
Brain Autoimmunity and Intestinal Microbiota: 100 Trillion Game Changers
Wekerle, H. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.03.008 · Cited by 101 · see citing works
Averina, O. V., Kovtun, A. S., Polyakova, S. I., Savilova, A. M., Rebrikov, D. V., & Даниленко, В. Н. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001178 · Cited by 103 · see citing works
Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection
D’Haens, G., & Jobin, C. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.053 · Cited by 98 · see citing works
Dargenio, V. N., Dargenio, C., Castellaneta, S., De Giacomo, A., Laguardia, M., Schettini, F., Francavilla, R., & Cristofori, F. (2023) · Nutrients · doi:10.3390/nu15071620 · Cited by 98 · see citing works
Analysis of the Duodenal Microbiome in Autistic Individuals: Association With Carbohydrate Digestion
Kushak, R. I., Winter, H. S., Buie, T. M., Cox, S. B., Phillips, C. D., & Ward, N. L. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001458 · Cited by 92 · see citing works
Hung, L. Y., & Margolis, K. G. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00857-1 · Cited by 96 · see citing works
Low-Abundant Microorganisms: The Human Microbiome’s Dark Matter, a Scoping Review
de Cena, J. A., Zhang, J., Deng, D., Damé‐Teixeira, N., & Do, T. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.689197 · Cited by 88 · see citing works
Lim, J. S., Lim, M. Y., Choi, Y., & Ko, G. (2017) · Molecular Brain · doi:10.1186/s13041-017-0292-0 · Cited by 85 · see citing works
Dong, T. S., & Mayer, E. A. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.024 · Cited by 84 · see citing works
Gestational Diabetes Is Uniquely Associated With Altered Early Seeding of the Infant Gut Microbiota
Soderborg, T. K., Carpenter, C. M., Janssen, R. C., Weir, T. L., Robertson, C. E., Ir, D., Young, B. E., Krebs, N. F., Hernandez, T. L., Barbour, L. A., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.603021 · Cited by 82 · see citing works
Self-citationMicrobiota in Autism Spectrum Disorder: A Systematic Review
Lewandowska, Z., Figlerowicz, M., & Mazur‐Melewska, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316660 · Cited by 82 · see citing works
Oral microbiome activity in children with autism spectrum disorder
Hicks, S. D., Uhlig, R., Afshari, P., Williams, J. R., Chroneos, M. Z., Tierney‐Aves, C., Wagner, K. E., & Middleton, F. A. (2018) · Autism Research · doi:10.1002/aur.1972 · Cited by 80 · see citing works
Gargari, G., Taverniti, V., Balzaretti, S., Ferrario, C., Gardana, C., Simonetti, P., & Guglielmetti, S. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.01753-16 · Cited by 79 · see citing works
Gevi, F., Belardo, A., & Zolla, L. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165859 · Cited by 77 · see citing works
An approach to gut microbiota profile in children with autism spectrum disorder
Andreo‐Martínez, P., García-Martínez, N., Sánchez‐Samper, E. P., & Martínez‐González, A. E. (2019) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12810 · Cited by 76 · see citing works
Systematic Review: Autism Spectrum Disorder and the Gut Microbiota
Korteniemi, J., Karlsson, L., & Aatsinki, A. (2023) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13587 · Cited by 77 · see citing works
Incontinence in autism spectrum disorder: a systematic review
Niemczyk, J., Wagner, C., & von Gontard, A. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1062-3 · Cited by 75 · see citing works
The Brain-Gut-Microbiome Axis: What Role Does it Play in Autism Spectrum Disorder?
Luna, R. A., Savidge, T., & Williams, K. C. (2016) · Current Developmental Disorders Reports · doi:10.1007/s40474-016-0077-7 · Cited by 73 · see citing works
Oral microbiota and autism spectrum disorder (ASD)
Olsen, I., & Hicks, S. D. (2019) · Journal of Oral Microbiology · doi:10.1080/20002297.2019.1702806 · Cited by 73 · see citing works
Gastrointestinal alterations in autism spectrum disorder: What do we know?
Bjørklund, G., Pivina, L. M., Dadar, M., Meguid, N. A., Semenova, Y. M., Anwar, M., & Chirumbolo, S. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.033 · Cited by 70 · see citing works
Ahmed, S. M., El-Hefnawy, A. M., Azouz, H. G., Roshdy, Y. S., Ashry, M. H., Ibrahim, A. E., & Meheissen, M. A. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01500-3 · Cited by 72 · see citing works
The Role of Gut Microbiota in Gastrointestinal Symptoms of Children with ASD
Martínez-González, A. E., & Andreo-Martínez, P. (2019) · Medicina · doi:10.3390/medicina55080408 · Cited by 67 · see citing works
Bundgaard-Nielsen, C., Lauritsen, M. B., Knudsen, J., Rold, L. S., Larsen, M., Hindersson, P., Villadsen, A., Leutscher, P., Hagstrøm, S., Nyegaard, M., et al. (2023) · Gut microbes · doi:10.1080/19490976.2023.2211923 · Cited by 66 · see citing works
Lasheras, I., Seral, P., Latorre, E., Barroso, E., Gracia‐García, P., & Santabárbara, J. (2019) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2019.101874 · Cited by 64 · see citing works
Comparative study of classifiers for human microbiome data
Wang, X., & Liu, Y. (2020) · Medicine in Microecology · doi:10.1016/j.medmic.2020.100013 · Cited by 61 · see citing works
Berding, K., Holscher, H. D., Arthur, A. E., & Donovan, S. M. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.01.002 · Cited by 61 · see citing works
Gut microbiome: An intermediary to neurotoxicity
Dempsey, J. L., Little, M., & Cui, J. Y. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.005 · Cited by 62 · see citing works
The developing airway and gut microbiota in early life is influenced by age of older siblings
Christensen, E. D., Hjelmsø, M. H., Thorsen, J., Shah, S. A., Redgwell, T. A., Poulsen, C. E., Trivedi, U., Russel, J., Gupta, S., Chawes, B., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01305-z · Cited by 59 · see citing works
Cristiano, C., Lama, A., Lembo, F., Mollica, M. P., Calignano, A., & Raso, G. M. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00184 · Cited by 57 · see citing works
Elucidating the Beta-Diversity of the Microbiome: from Global Alignment to Local Alignment
Su, X. (2021) · mSystems · doi:10.1128/msystems.00363-21 · Cited by 57 · see citing works
Ye, F., Gao, X., Wang, Z., Cao, S., Liang, G., He, D., Lv, Z., Wang, L., Xu, P., & Zhang, Q. (2021) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2021.03.003 · Cited by 56 · see citing works
Kohli, M., Kar, A. K., & Sinha, S. (2022) · IEEE Access · doi:10.1109/access.2022.3208587 · Cited by 62 · see citing works
Gut Microbiota in Psychiatric Disorders: A Systematic Review
Chen, L. L., Abbaspour, A., Mkoma, G. F., Bulik, C. M., Rück, C., & Djurfeldt, D. R. (2021) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000959 · Cited by 54 · see citing works
Pietrucci, D., Teofani, A., Milanesi, M., Fosso, B., Putignani, L., Messina, F., Pesole, G., Desideri, A., & Chillemi, G. (2022) · Biomedicines · doi:10.3390/biomedicines10082028 · Cited by 54 · see citing works
Eshraghi, R. S., Deth, R. C., Mittal, R., Aranke, M., Kay, S.-I. S., Moshiree, B., & Eshraghi, A. A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00256 · Cited by 55 · see citing works
Gut Microbiome and Modulation of <scp>CNS</scp> Function
Osadchiy, V., Martin, C. R., & Mayer, E. A. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c180031 · Cited by 53 · see citing works
Comparing the Gut Microbiome in Autism and Preclinical Models: A Systematic Review
Alamoudi, M. U. A., Hosie, S., Shindler, A. E., Wood, J. L., Franks, A. E., & Hill‐Yardin, E. L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.905841 · Cited by 52 · see citing works
The gut microbiome in psychiatry: A primer for clinicians
Ameringen, M. V., Turna, J., Patterson, B. A., Pipe, A., Mao, R. Q., Anglin, R., & Surette, M. G. (2019) · Depression and Anxiety · doi:10.1002/da.22936 · Cited by 51 · see citing works
Medeiros, K., Mazurek, M. O., & Kanne, S. (2017) · Research in Autism Spectrum Disorders · doi:10.1016/j.rasd.2017.06.001 · Cited by 50 · see citing works
The microbiome and childhood diseases: Focus on brain‐gut axis
O’Mahony, S. M., Stilling, R. M., Dinan, T. G., & Cryan, J. F. (2015) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21118 · Cited by 50 · see citing works
A Systematic Review of the Microbiome in Children With Neurodevelopmental Disorders
Lacorte, E., Gervasi, G., Bacigalupo, I., Vanacore, N., Raucci, U., & Parisi, P. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00727 · Cited by 48 · see citing works
Gut-to-Brain Axis in Autism Spectrum Disorders
Kraneveld, A. D., Szklany, K., de Theije, C. G. M., & Garssen, J. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.09.001 · Cited by 47 · see citing works
Targeting Gut Microbiota Dysbiosis: Potential Intervention Strategies for Neurological Disorders
Wu, W., Kong, Q., Tian, P., Zhai, Q., Wang, G., Liu, X., Zhao, J., Zhang, H., Lee, Y. K., & Chen, W. (2020) · Engineering · doi:10.1016/j.eng.2019.07.026 · Cited by 48 · see citing works
Dietary interventions for autism spectrum disorder: New perspectives from the gut-brain axis
Doenyas, C. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.07.014 · Cited by 46 · see citing works
Potential of gut microbiome for detection of autism spectrum disorder
Wu, T., Wang, H., Lu, W., Zhai, Q., Zhang, Q., Yuan, W., Gu, Z., Zhao, J., Zhang, H., & Chen, W. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104568 · Cited by 46 · see citing works
Between Dysbiosis, Maternal Immune Activation and Autism: Is There a Common Pathway?
Suprunowicz, M., Tomaszek, N., Urbaniak, A., Zackiewicz, K., Modzelewski, S., & Waszkiewicz, N. (2024) · Nutrients · doi:10.3390/nu16040549 · Cited by 44 · see citing works
Lagod, P. P., & Naser, S. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417432 · Cited by 49 · see citing works
Gut microbiota, metabolism and psychopathology: A critical review and novel perspectives
Groen, R. N., de Clercq, N. C., Nieuwdorp, M., Hoenders, R. H. J., & Groen, A. K. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1463507 · Cited by 43 · see citing works
Gut Microbiota Profiles in Children and Adolescents with Psychiatric Disorders
Šoltýsová, M., Tomova, A., & Ostatníková, D. (2022) · Microorganisms · doi:10.3390/microorganisms10102009 · Cited by 44 · see citing works
Caputi, V., Hill, L., Figueiredo, M., Popov, J., Hartung, E., Margolis, K. G., Baskaran, K., Joharapurkar, P., Moshkovich, M., & Pai, N. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1341656 · Cited by 41 · see citing works
- Authors
- Son, J. S., Zheng, L. J., Rowehl, L. M., Tian, X., Zhang, Y., Zhu, W., Litcher-Kelly, L., Gadow, K. D., Gathungu, G., Robertson, C. E., Ir, D., Frank, D. N., & Li, E.
- Affiliations
- Stony Brook University (US)
- University of Colorado Anschutz (US)
- Corresponding author
- Li, Ellen
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-10-01
- Volume
- 10
- Issue
- 10
- Pages
- e0137725
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4591364
- OpenAlex
- W1860290282
- Cited by
- 229
- References
- 73
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 23 · 2023: 17 · 2022: 18 · 2021: 29 · 2020: 29 · 2019: 33 · 2018: 24 · 2017: 13 · 2016: 14 · 2015: 1 · 2014: 1
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Academic Commons (Stony Brook University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Simons Foundation
- Simons Foundation Autism Research Initiative
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- autism spectrum disorder, fecal microbiota, functional gastrointestinal disorders, constipation, siblings, gut microbiota, Sutterella, Bacteroidetes, Prevotella, child behavior problems, macronutrient intake, ASD severity, microbial taxa
- MeSH terms
- Autism Spectrum Disorder, Adolescent, Bacteria, Child, Diet, Feces, Female, Humans, Male, Phenotype, RNA, Ribosomal, 16S, Case-Control Studies, Siblings, Gastrointestinal Tract, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review